
IMHOTEP, PJP, and more
May 14, 2026 - 00:09:59
Radio and PodcastLive Radio & Podcasts
Lots of FDA approval updates to discuss from the past few weeks: -Zongertinib gets approved in 1st line setting for ERBB2 TKD mutated metastatic NSLCLC -Encorafenib approval with cetuximab + FOLFOX -Teclistamab + Daratum...
FDA Approval Updates Galore is an episode from OncoPharm by OncoPharmPod. Lots of FDA approval updates to discuss from the past few weeks: -Zongertinib gets approved in 1st line setting for ERBB2 TKD mutated metastatic NSLCLC -Encorafenib a...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published Mar 12, 2026, 00:12:47 long, audio available.
Lots of FDA approval updates to discuss from the past few weeks: -Zongertinib gets approved in 1st line setting for ERBB2 TKD mutated metastatic NSLCLC -Encorafenib approval with cetuximab + FOLFOX -Teclistamab + Daratumumab approved in 2nd line setting for r/r multiple myeloma -Acalabrutinib + venetoclax (but NOT acalabrutinib + venetoclax + obinutuzumab) is approved for CLL Check out the Oncology Insights Newsletter:
You can listen to FDA Approval Updates Galore online on Radio and Podcast. Open the player on this page to stream the available audio.
FDA Approval Updates Galore is an episode from OncoPharm by OncoPharmPod.
This episode is 00:12:47 long.
This episode was published on Mar 12, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.